Workforce mental health isn't just an HR issue, it's also a business imperative. Companies that integrate evidence-based solutions into their benefits reduce medical costs, improve productivity, and retain top talent.
The FDA approved Spravato in March, but a new paper in JAMA examines some of the barriers inherent in the practice and reimbursement of psychiatry that could get in the way of widespread use of the drug.
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.
The drug, a reformulation of ketamine, was approved for patients who have failed on other antidepressants. The original form of ketamine, approved as an anesthetic, has long been explored as a treatment for depression.